NCT01425892 The Pathogenesis and Natural History of Sjogren's Disease
| NCT ID | NCT01425892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Dental and Craniofacial Research (NIDCR) |
| Condition | Sjogren's Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2012-01-18 |
| Primary Completion | — |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2012-01-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: -Sjogren s Disease (formerly: Sjogrens Syndrome, Sj(SqrRoot)(Delta)gren s syndrome) is a disease that affects about 1-4 million Americans. It is more common in women. It mainly affects the glands that produce saliva and tears, leading to dry eyes and dry mouth. The cause of Sjogren s Disease is unknown, but inflammation plays an important role. The purpose of this study is to learn more about Sjogren s Disease. Objectives: -To better understand how Sjogren s Disease begins and how it affects patients so that we can develop better ways to treat them. Eligibility: * Participants must be 16 years of age or older. * They must have a diagnosis of Sjogren s Disease or have at least two symptoms of Sjogren s Disease. Design: * People taking part in the study will come to the NIH Clinical Center for at least three visits. * During these visits, participants will have a medical history and physical exam. They will have oral and dental assessments, and saliva collection. Lab tests (blood and urine) and dry eye exams will be done. Participants will answer questionnaires and have salivary scintigraphy (adults only unless required for diagnosis). * Other optional tests may also be done. Participants may have to come in for additional visits if they have these optional tests or if their disease changes. * The only treatment provided as part of this study is for medical emergencies or complications that occur while you are at NIH for evaluation....
Eligibility Criteria
* INCLUSION CRITERIA: 1. Ability to sign informed consent form 2. Fulfilling one the definitions below: 1. Sjogren s defined by European-American (EA) classification criteria for primary or secondary Sjogren s Disease (SjD group) 2. Excluded from the EA criteria because of a comorbid condition but otherwise fulfilling the European-American classification criteria (EA excluded SjD group) 3. Incomplete SjD i. at least 2 of the EA criteria with a common manifestation of SjD not included in these criteria (e.g., fatigue, vasculitis, arthritis, etc) or ii. 2 or more common manifestations of SjD which are not included in the EA criteria (e.g.,: fatigue, vasculitis, arthritis, autonomic dysfunction, etc ) and are not explained by other conditions EXCLUSION CRITERIA: <!-- --> 1. Age \<16 years 2. inability or unwillingness to comply with follow up requirements 3. Any medical or psychological/psychiatric condition or treatment that, in the opinion of the Principal Investigator, would exclude the subjects from the research studies (e.g., alternative explanation for subjects signs and symptoms) 4. NIH employees who report directly to the principal investigator or who are a co-worker or relative of the principal investigator.
Contact & Investigator
Zohreh Khavandgar, D.D.S.
PRINCIPAL INVESTIGATOR
National Institute of Dental and Craniofacial Research (NIDCR)
Frequently Asked Questions
Who can join the NCT01425892 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 100 Years, studying Sjogren's Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01425892 currently recruiting?
Yes, NCT01425892 is actively recruiting participants. Contact the research team at eileen.pelayo@nih.gov for enrollment information.
Where is the NCT01425892 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT01425892 clinical trial?
NCT01425892 is sponsored by National Institute of Dental and Craniofacial Research (NIDCR). The principal investigator is Zohreh Khavandgar, D.D.S. at National Institute of Dental and Craniofacial Research (NIDCR). The trial plans to enroll 300 participants.